CPP
CTSO icon

Crow Point Partners’s Cytosorbents Corp CTSO Stock Holding History

Crow Point Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-42,001
Closed -$214K – 88
2019
Q3 		$214K Sell
42,001
-3,360
-7% -$19.5K 0.03% 106
2019
Q2 		$300K Sell
45,361
-9,665
-18% -$66.4K 0.05% 82
2019
Q1 		$417K Buy
55,026
+6,450
+13% +$50.2K 0.07% 64
2018
Q4 		$380K Buy
48,576
+575
+1% +$5.71K 0.07% 68
2018
Q3 		$619K Buy
48,001
+2,963
+7% +$37.1K 0.11% 69
2018
Q2 		$518K Buy
45,038
+34,382
+323% +$326K 0.1% 70
2018
Q1 		$75K Buy
10,656
+1,642
+18% +$12.4K 0.01% 163
2017
Q4 		$59K Buy
+9,014
New +$57.3K 0.01% 195

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Crow Point Partners's CTSO Position: Q4 2019 in Review

Crow Point Partners sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 42,001 shares — an estimated $214K sold.

Crow Point Partners first reported a position in CTSO in Q4 2017 and held it in 8 quarters. The position peaked at $619K in Q3 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Crow Point Partners reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • Crow Point Partners sold 42,001 Cytosorbents Corp shares in Q4 2019, an estimated $214K.
  • Crow Point Partners first reported a position in Cytosorbents Corp in Q4 2017 and held it in 8 quarters.
  • Crow Point Partners's Cytosorbents Corp position peaked at $619K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.